GSK’s Move to Cambridge Leaves Stevenage Facing an Uncertain Future
GSK’s decision to move its main research and development operation from Stevenage to Cambridge is creating uncertainty for a town ...
GSK’s decision to move its main research and development operation from Stevenage to Cambridge is creating uncertainty for a town ...
New CEO Sets Ambitious Growth Target Shares in Oxford Nanopore Technologies surged after newly appointed Chief Executive Officer Francis Van ...
Fast-Growing Pharmaceutical Companies Struggle to Recruit International Experts for Overseas Growth Chinese pharmaceutical companies are encountering a major obstacle in ...
Swiss Drugmaker Expands Cancer Portfolio With Next-Generation Antibody-Drug Conjugate Technology Swiss pharmaceutical giant Novartis has agreed to acquire UK biotechnology ...
The agreement gives Innovent Biologics exclusive commercialization rights for Eli Lilly's breast cancer drug Verzenios in mainland China, as the ...